Electroporation as a method to induce myofiber regeneration and increase the engraftment of myogenic cells in skeletal muscles of primates

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 8, 2013, Pages 723-734

  Skuk, Daniel ^a   Goulet, Marlyne ^a   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Electroporation; Myoblasts; Myogenic cell transplantation; Nonhuman primates; Skeletal muscle

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ELECTROPORATION; ENGRAFTMENT; FEMALE; HISTOLOGY; MACACA FASCICULARIS; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE INJURY; MUSCLE NECROSIS; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; BETA-GALACTOSIDASE; COMPLEMENT MEMBRANE ATTACK COMPLEX; DESMIN; ELECTROPORATION; FEMALE; INJECTIONS, INTRAMUSCULAR; MACACA FASCICULARIS; MALE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; REGENERATION; TIME FACTORS;

EID: 84880920236     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31829bac22     Document Type: Article

References (57)

1. Kikuchi T, Doerr L, Ashmore CR. A possible mechanism of phenotypic expression of normal and dystrophic genomes on succinic dehydrogenase activity and fiber size within a single myofiber of muscle transplants. J Neurol Sci 1980;45:273-86 (Pubitemid 10133725)
2. Peault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007; 15:867-77 (Pubitemid 46621645)
3. Vilquin JT, Catelain C, Vauchez K. Cell therapy for muscular dystrophies: Advances and challenges. Curr Opin Organ Transplant 2011;16: 640-49
4. Pannerec A, Marazzi G, Sassoon D. Stem cells in the hood: The skeletal muscle niche. Trends Mol Med 2012;18:599-606
5. Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchennés muscular dystrophy. N Engl J Med 1995;333: 832-38
6. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65:371-86 (Pubitemid 44264834)
7. Skuk D, Goulet M, Roy B, et al. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 2007;17:38-46 (Pubitemid 46188617)
8. Skuk D, Tremblay JP. Intramuscular cell transplantation as a potential treatment of myopathies: Clinical and preclinical relevant data. Expert Opin Biol Ther 2011;11:359-74
9. Skuk D, Goulet M, Tremblay JP. Intramuscular transplantation of myogenic cells in primates: Importance of needle size, cell number and injection volume. Cell Transplantation 2013; [Epub ahead of print]
10. Skuk D, Goulet M, Tremblay JP. Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle. J Neuropathol Exp Neurol 2011;70:770-78
11. Robertson TA, Maley MA, Grounds MD, et al. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 1993;207:321-31 (Pubitemid 23246804)
12. Bischoff R. Chemotaxis of skeletal muscle satellite cells. Dev Dyn 1997; 208:505-15 (Pubitemid 27152842)
13. Tokura Y, Nakayama Y, Fukada S, et al. Muscle injury-induced thymosin beta4 acts as a chemoattractant for myoblasts. J Biochem 2011; 149:43-48
14. Skuk D, Goulet M, Paradis M, et al. Myoblast transplantation: Techniques in nonhuman primates as a bridge to clinical trials. In: Soto-Gutierrez A, Navarro-Alvarez N, Fox IJ, eds. Methods in Bioengineering: Cell Transplantation. Boston, MA: Artech House, 2011: 219-36
15. Kinoshita I, Vilquin JT, Guerette B, et al. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve 1994;17:1407-15 (Pubitemid 24362813)
16. Vilquin JT, Asselin I, Guerette B, et al. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation 1995; 59:422-26
17. Pin CL, Merrifield PA. Developmental potential of rat L6 myoblasts in vivo following injection into regenerating muscles. Dev Biol 1997; 188:147-66 (Pubitemid 27360094)
18. Cantini M, Massimino ML, Catani C, et al. Gene transfer into satellite cell from regenerating muscle: Bupivacaine allows beta-Gal transfection and expression in vitro and in vivo. In Vitro Cell Dev Biol Anim 1994; 30A:131-33 (Pubitemid 24164793)
19. Wernig A, Irintchev A, Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J Physiol (Lond) 1995;484:493-504
20. Irintchev A, Langer M, Zweyer M, et al. Functional improvement of damaged adult mouse muscle by implantation of primary myoblasts. J Physiol (Lond) 1997;500:775-85 (Pubitemid 27207834)
21. Negroni E, Riederer I, Chaouch S, et al. In vivo myogenic potential of human CD133(+) muscle-derived stem cells: A quantitative study. Mol Ther 2009;17:1771-78
22. Skuk D, Goulet M, Roy B, et al. Myoblast transplantation in whole muscle of nonhuman primates. J Neuropathol Exp Neurol 2000;59: 197-206 (Pubitemid 30143878)
23. Skuk D, Roy B, Goulet M, et al. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle. Exp Neurol 1999;155:22-30 (Pubitemid 29072601)
24. Carlson BM. Muscle regeneration in animal models. In: Schiaffino S, Partridge T, eds. Skeletal Muscle Repair and Regeneration. Dordrecht, Netherlands: Springer, 2008:163-79
25. Ham RG, St. Clair JA, Webster C, et al. Improved media for normal human muscle satellite cells: Serum-free clonal growth and enhanced growth with low serum. In Vitro Cell Dev Biol 1988;24:833-44
26. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006;15:659-63 (Pubitemid 44904677)
27. Engel AG, Biesecker G. Complement activation in muscle fiber necrosis: Demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol 1982;12:289-96 (Pubitemid 12053038)
28. Hojman P. Basic principles and clinical advancements of muscle electrotransfer. Curr Gene Ther 2010;10:128-38
29. Bigey P, Bureau MF, Scherman D. In vivo plasmid DNA electrotransfer. Curr Opin Biotechnol 2002;13:443-47
30. Trollet C, Scherman D, Bigey P. Delivery of DNA into muscle for treating systemic diseases: Advantages and challenges. Methods Mol Biol 2008;423:199-214
31. Millay DP, Goonasekera SA, Sargent MA, et al. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc Natl Acad Sci U S A 2009;106:19023-28
32. Trollet C, Bloquel C, Scherman D, et al. Electrotransfer into skeletal muscle for protein expression. Curr Gene Ther 2006;6:561-78 (Pubitemid 44524460)
33. Mathiesen I. Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther 1999;6:508-14 (Pubitemid 29192659)
34. Otten G, Schaefer M, Doe B, et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 2004;22:2489-93 (Pubitemid 38757348)
35. Lepper C, Partridge TA, Fan CM. An absolute requirement for Pax7- positive satellite cells in acute injury-induced skeletal muscle regeneration. Development 2011;138:3639-46
36. Sambasivan R, Yao R, Kissenpfennig A, et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development 2011;138:3647-56
37. Carlson BM. Muscle regeneration in amphibians and mammals: Passing the torch. Dev Dyn 2003;226:167-81 (Pubitemid 36158163)
38. Gehl J, Sorensen TH, Nielsen K, et al. In vivo electroporation of skeletal muscle: Threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1999;1428:233-40 (Pubitemid 29352271)
39. Skuk D, Goulet M, Roy B, et al. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: Toward defining strategies applicable to humans. Exp Neurol 2002; 175:112-26 (Pubitemid 34507914)
40. El Fahime E, Mills P, Lafreniere JF, et al. The urokinase plasminogen activator: An interesting way to improve myoblast migration following their transplantation. Exp Cell Res 2002;280:169-78 (Pubitemid 35333759)
41. Mills P, Dominique JC, Lafreniere JF, et al. A synthetic mechano growth factor E Peptide enhances myogenic precursor cell transplantation success. Am J Transplant 2007;7:2247-59 (Pubitemid 47347850)
42. Lafreniere JF, Caron MC, Skuk D, et al. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplantation 2009; 18:719-30
43. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010;298:R1173-87
44. Thomson AW, Bonham CA, Zeevi A. Mode of action of tacrolimus (FK506): Molecular and cellular mechanisms. Ther Drug Monit 1995; 17:584-91
45. Yoshino T, Nakase H, Honzawa Y, et al. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflamm Bowel Dis 2010;16:2022-33
46. Borisov AB. Regeneration of skeletal and cardiac muscle in mammals: Do nonprimate models resemble human pathology? Wound Repair Regen 1999;7:26-35 (Pubitemid 29159038)
47. Dewald O, Ren G, Duerr GD, et al. Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction. Am J Pathol 2004;164:665-77 (Pubitemid 38364680)
48. Mestas J, Hughes CC. Of mice and not men: Differences between mouse and human immunology. J Immunol 2004;172:2731-38 (Pubitemid 38263654)
49. Kirk AD. Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999;19:349-88 (Pubitemid 30053171)
50. Mali B, Jarm T, Snoj M, et al. Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis. Eur J Surg Oncol 2013;39:4-16
51. Low L, Mander A, McCann K, et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009;20:1269-78
52. Vasan S, Hurley A, Schlesinger SJ, et al. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS One 2011;6:e19252
53. Roman M, Axelrod JH, Dai Y, et al. Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat Cell Mol Genet 1992;18:247-58
54. Hamamori Y, Samal B, Tian J, et al. Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest 1995; 95:1808-13
55. Dhawan J, Pan LC, Pavlath GK, et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 1991;254:1509-12 (Pubitemid 21917491)
56. Simonson GD, Groskreutz DJ, Gorman CM, et al. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures. Hum Gene Ther 1996;7:71-78 (Pubitemid 26119485)
57. Dhawan J, Rando TA, Elson SE, et al. Myoblast-mediated expression of colony stimulating factor-1 (CSF-1) in the cytokinedeficient op/op mouse. Somat Cell Mol Genet 1996;22:363-81 (Pubitemid 27097790)